Related Experiment Video
Updated: Jan 5, 2026
05:18
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
1.8K
Treating SIRVA Early With Corticosteroid Injections: A Case Series
Christopher V Macomb1, Martin O Evans2, Jo E Dockstader3
1Internal Medicine, Walter Reed National Military Medical Center, 4494 N Palmer Rd, Bldg 19, Rm 2500, Bethesda, MD 20889.
Military Medicine
|October 18, 2019
Summary
Corticosteroid injections (CSIs) may effectively treat shoulder pain and limited motion after vaccine administration (SIRVA). This study suggests CSIs could be a first-line treatment option for SIRVA, offering faster symptom resolution.
Area of Science:
- Immunology
- Orthopedics
- Pharmacology
Background:
- Shoulder injury related to vaccine administration (SIRVA) presents as shoulder pain and limited range of motion post-vaccination.
- Current evidence on the efficacy of corticosteroid injections (CSIs) for SIRVA is limited.
- SIRVA can lead to prolonged pain, with 65% experiencing pain beyond one month and 25% beyond three months per CDC data.
Observation:
- This case series details two patients diagnosed with SIRVA.
- Both patients received corticosteroid injections (CSIs) within five days of symptom onset.
- Symptom resolution was observed within one month following CSI administration.
Findings:
- The two patients in this case series experienced complete symptom resolution within one month after receiving corticosteroid injections.
- This contrasts with existing data indicating prolonged pain in a significant percentage of SIRVA patients.
- The findings suggest corticosteroid injections may be an effective treatment for SIRVA.
Implications:
- Corticosteroid injections (CSIs) show promise as a first-line treatment for shoulder injury related to vaccine administration (SIRVA).
- CSIs should be considered, particularly for patients with contraindications to nonsteroidal anti-inflammatory drugs (NSAIDs).
- Further research is warranted to confirm the efficacy and optimal use of CSIs in managing SIRVA.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
388
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
388
01:26COPD: Management Using Bronchodilators and Corticosteroids
686
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
686
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
443
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
443
01:17Pericarditis III: Medical Management
265
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
265
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
409
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
409